Microbiology · Mycobacterial and Fungal Diagnostics (NAAT, LPA, Culture, DST, IGRA, Galactomannan)

Phenotypic drug susceptibility testing shows resistance to pyrazinamide in an M. tuberculosis isolate. Mutations in which gene account for the large majority of pyrazinamide resistance?

  • A rpsA, encoding ribosomal protein S1
  • B embB, encoding arabinosyltransferase
  • C pncA, encoding pyrazinamidase
  • D inhA promoter region
Correct answer: C. pncA, encoding pyrazinamidase

Explanation

Pyrazinamide is a prodrug converted to active pyrazinoic acid by the bacterial pyrazinamidase encoded by pncA. Loss-of-function mutations in pncA explain most pyrazinamide resistance worldwide, which is why pncA sequencing is proposed as a molecular marker for PZA resistance. embB mutations confer ethambutol resistance and inhA promoter mutations confer isoniazid resistance. rpsA and panD are rare alternative loci, not the major mechanism.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Mycobacterial and Fungal Diagnostics (NAAT, LPA, Culture, DST, IGRA, Galactomannan) MCQs

See all Mycobacterial and Fungal Diagnostics (NAAT, LPA, Culture, DST, IGRA, Galactomannan) MCQs →